The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot Study

National Cancer Center (NCC)

Status and phase: Completed; Phase 4

Conditions: Cancers, Pain

Treatments: Drug: Cancer pain management

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01043068

CAPAM-1

Details and patient eligibility

About

The purpose of this study was to prospectively evaluate the effect of cancer pain management protocol on hospitalized cancer patients.

Enrollment: 25 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hospitalized patient with the somatic and/or visceral pain having an untreated intensity greater than 3 on a 10 cm visual analog scale (VAS; 0 = no pain, 10 = unbearable pain)over the week prior to enrollment
• A minimum age of 18 years

Exclusion criteria

• Opioid intolerance
• No longer treatment for their underlying disease.
• Intracerebral primary or metastatic lesion
• Impaired sensory or cognitive function
• Pregnant or lactating woman
• Women of child bearing potential not using a contraceptive method
• Sexually active fertile men not using effective birth control during medication of study drug and up to 6 months after completion of study drug if their partners are women of child-bearing potential
• Any patients judged by the investigator to be unfit to participate in the study

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

25 participants in 1 patient group

Pain control

Experimental group

Description:

Interventions based on published pain guideline. The interventions consisted of the following: (1) nursing pain assessment of current pain, worst pain, pain relief, and acceptability of pain; (2) feedback to guide analgesic prescribing by physician.

Treatment:

Drug: Cancer pain management